Plans to produce molybdenum-99 (Mo-99) at OPG’s Darlington nuclear power station in Canada are making “significant progress” with the manufacturing of specialised tooling for the project underway at a facility in Peterborough, Ontario.
The project to produce Mo-99 at Darlington involves Darlington owner and operator OPG, its subsidiary Laurentis Energy Partners, BWXT and a number of BWXT affiliates. The project could see Darlington become the first commercial operating nuclear reactor to produce Mo-99, OPG said.
Mo-99 is a much-needed medical isotope used in over 40 million procedures a year to detect cancers and diagnose various medical conditions.
…